FindTrial
Sign In

Low dose macrolide used in stable COPD

Low dose macrolide used in stable COPD - Low dose macrolide used in stable COPD

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000050691
Enrollment
Unknown
Registered
2023-03-27
Start date
2023-03-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Interventions

None listed

Sponsors

Yokohama City Uiversity
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. COPD 2. Macrolide used

Exclusion criteria

Exclusion criteria: 1. COPD acute phase 2. short term usage of macrolide

Design outcomes

Primary

MeasureTime frame
COPD execerbation—

Countries

Japan,Asia(except Japan),North America,South America,Australia,Europe,Africa

Contacts

Public ContactHao Chen

Yokohama Minami Kyousai Hospital Chemotheraoy Department

chinsmd@gmail.com045-782-2101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026